Home › Kanser sa Tiyan
Pag-aaral pangklinika para sa Kanser sa Tiyan na nagre-recruit sa U.S.
135 pag-aaral para sa Kanser sa Tiyan ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX44 pag-aaral
- New York City, NY33 pag-aaral
- Boston, MA32 pag-aaral
- Nashville, TN27 pag-aaral
- Los Angeles, CA23 pag-aaral
- Arlington, VA21 pag-aaral
- Baldwin Park, CA21 pag-aaral
- Dallas, TX20 pag-aaral
- San Antonio, TX20 pag-aaral
- Grand Rapids, MI20 pag-aaral
- Chicago, IL19 pag-aaral
- St. Louis, MO18 pag-aaral
- Washington, DC16 pag-aaral
- Detroit, MI15 pag-aaral
- Pittsburgh, PA14 pag-aaral
- Philadelphia, PA13 pag-aaral
- Orange, CA13 pag-aaral
- Portland, OR13 pag-aaral
- Cleveland, OH12 pag-aaral
- Queens, NY12 pag-aaral
- Denver, CO11 pag-aaral
- Orlando, FL11 pag-aaral
- Atlanta, GA11 pag-aaral
- Madison, WI11 pag-aaral
- Mountain View, CA11 pag-aaral
- Durham, NC10 pag-aaral
- Oklahoma City, OK10 pag-aaral
- Seattle, WA10 pag-aaral
- Aurora, CO10 pag-aaral
- Edison, NJ10 pag-aaral
- Kansas City, MO10 pag-aaral
- Austin, TX9 pag-aaral
- Charlotte, NC9 pag-aaral
- New Haven, CT9 pag-aaral
- Omaha, NE9 pag-aaral
- San Francisco, CA9 pag-aaral
- Irving, TX9 pag-aaral
- San Diego, CA9 pag-aaral
- Columbus, OH9 pag-aaral
- Tampa, FL9 pag-aaral
Ayos sa estado
- Alabama6 pag-aaral
- Alaska4 pag-aaral
- Arizona12 pag-aaral
- Arkansas6 pag-aaral
- California68 pag-aaral
- Colorado23 pag-aaral
- Connecticut11 pag-aaral
- Delaware4 pag-aaral
- District of Columbia4 pag-aaral
- Florida37 pag-aaral
- Georgia12 pag-aaral
- Idaho3 pag-aaral
- Illinois21 pag-aaral
- Indiana9 pag-aaral
- Iowa9 pag-aaral
- Kansas9 pag-aaral
- Kentucky9 pag-aaral
- Louisiana5 pag-aaral
- Maine3 pag-aaral
- Maryland20 pag-aaral
- Massachusetts34 pag-aaral
- Michigan35 pag-aaral
- Minnesota17 pag-aaral
- Missouri23 pag-aaral
- Montana4 pag-aaral
- Nebraska9 pag-aaral
- Nevada5 pag-aaral
- New Jersey13 pag-aaral
- New Mexico5 pag-aaral
- New York41 pag-aaral
- North Carolina22 pag-aaral
- North Dakota4 pag-aaral
- Ohio23 pag-aaral
- Oklahoma11 pag-aaral
- Oregon14 pag-aaral
- Pennsylvania29 pag-aaral
- Rhode Island5 pag-aaral
- South Carolina9 pag-aaral
- South Dakota4 pag-aaral
- Tennessee30 pag-aaral
- Texas63 pag-aaral
- Utah14 pag-aaral
- Virginia29 pag-aaral
- Washington14 pag-aaral
- West Virginia4 pag-aaral
- Wisconsin19 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07360314Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01950572Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Nagre-recruit
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04907643Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
Nagre-recruitObservasyonal na pag-aaral
Edad 6 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT04557969GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07581405The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06995898Avutometinib and Defactinib in Diffuse Gastric Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06487221Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT04198766A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 19 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06586957A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07221149Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06885697cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05366881Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07283939A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07213791A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07114601Distance-Based Exercise to Preserve Function and Prevent Disability
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07059884A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06760819A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06695845A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07578571A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07069712A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07903415Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Nagre-recruitPhase 1/2
Edad 18 hanggang 72 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT03190941Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07124351A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT03526835Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.